DRG Range Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms

• 1  LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC     ( 820 )

• 2  LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC     ( 821 )

• 3  LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC     ( 822 )

• 4  LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC     ( 823 )

• 5  LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC     ( 824 )

• 6  LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC     ( 825 )

• 7  MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC     ( 826 )

• 8  MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC     ( 827 )

• 9  MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC     ( 828 )

• 10  MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC     ( 829 )

• 11  MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC     ( 830 )

• 12  ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH MCC     ( 834 )

• 13  ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH CC     ( 835 )

• 14  ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITHOUT CC/MCC     ( 836 )

• 15  CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC     ( 837 )

• 16  CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT     ( 838 )

• 17  CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC     ( 839 )

• 18  LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC     ( 840 )

• 19  LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC     ( 841 )

• 20  LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC     ( 842 )

• 21  OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC     ( 843 )

• 22  OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC     ( 844 )

• 23  OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC     ( 845 )

• 24  CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC     ( 846 )

• 25  CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC     ( 847 )

• 26  CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC     ( 848 )

• 27  RADIOTHERAPY     ( 849 )